Glaxosmithkline Limited
Dormant Company · London
ActiveUnited KingdomIncorporated 2019Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
12215835- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2019-09-19
- Jurisdiction
- —
- Registered office
- 79, NEW OXFORD STREET, LONDON, WC1A 1DG, UNITED KINGDOM
Classification
1 SIC codes99999
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
7 matched grantsGSK Barnard Castle - Energy EfficiencyLead
Innovate UK · Collaborative R&D · 2022-04-01 – 2024-03-31
£338,032
awarded
SmartPSC (Smart Pharma Supply Chain): Application of digital technologies to integrate pharma manufacturing supply chain and enhance efficiency, productivity, flexibility, resilience, and sustainabilityLeadInnovate UK · Collaborative R&D · 2021-06-01 – 2023-11-30 · with 4 other participants£822,518awarded
SmartPSC (Smart Pharma Supply Chain): Application of digital technologies to integrate pharma manufacturing supply chain and enhance efficiency, productivity, flexibility, resilience, and sustainabilityLead
Innovate UK · Collaborative R&D · 2021-06-01 – 2023-11-30 · with 4 other participants
£822,518
awarded
Glaxosmithkline Limitedlead£822,518
University of Cambridge£163,652
SmartPSC (Smart Pharma Supply Chain): Application of digital technologies to integrate pharma manufacturing supply chain and enhance efficiency, productivity, flexibility, resilience, and sustainabilityLeadISCF · Collaborative R&D · 2021-05-31 – 2023-11-30 · with 4 other participants£1,449,288whole project
SmartPSC (Smart Pharma Supply Chain): Application of digital technologies to integrate pharma manufacturing supply chain and enhance efficiency, productivity, flexibility, resilience, and sustainabilityLead
ISCF · Collaborative R&D · 2021-05-31 – 2023-11-30 · with 4 other participants
£1,449,288
whole project
Glaxosmithkline LimitedleadAstrazeneca PLCCentre For Process Innovation LimitedUniversity Of CambridgeWyoming Interactive Limited
SmartPSC (Smart Pharma Supply Chain): Application of digital technologies to integrate pharma manufacturing supply chain and enhance efficiency, productivity, flexibility, resilience, and sustainabilityISCF · Collaborative R&D · 2021-05-31 – 2023-11-30 · with 4 other participants£1,449,288whole project
SmartPSC (Smart Pharma Supply Chain): Application of digital technologies to integrate pharma manufacturing supply chain and enhance efficiency, productivity, flexibility, resilience, and sustainability
ISCF · Collaborative R&D · 2021-05-31 – 2023-11-30 · with 4 other participants
£1,449,288
whole project
Glaxosmithkline LimitedleadAstrazeneca PLCCentre For Process Innovation LimitedUniversity Of CambridgeWyoming Interactive Limited
Killing bacteria from within: In search of novel antibiotic targetsLead
UKRI Inn.Scholar · Study · 2021-02-01 – 2024-06-29
£212,432
whole project
Killing bacteria from within: In search of novel antibiotic targetsLead
Innovate UK · Study · 2021-02-01 – 2024-06-30
£212,432
awarded
Killing bacteria from within: In search of novel antibiotic targets
UKRI Inn.Scholar · Study · 2021-02-01 – 2024-06-29
£212,432
whole project